Dr Michael Seckl, a medical oncologist, and his team at the hospital found that treating cancerous cells with Taxol and stem cell infusion - an advanced form of bonemarrowtransplantation - was successful.
This, she adds, should be put into context: the development of bone-marrow transplantation or monoclonal-antibody treatments both took several decades.